2287 completed, 259 unknown, 174 recruiting, 135 terminated. 1181 Not applicable, 522 Phase 1, 438 Phase 2, 273 Phase 3, 212 Phase 4.
Follow Slow Virus Diseases: new trials by email Literature Review of Slow Virus Diseases trials Research Report on Slow Virus Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization smART (Smart Antiretroviral Therapy Assistant), Traditional Prescribing resources - HIV (Human Immunodeficiency Virus), Clinical Decision Support System (CDSS) | Not applicable | Not yet recruiting | Keck School of Medicine of USC | 250 | 2028-09-01 | 2025-10-22 |
| Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV Brief Videos for HIV Stigma - HIV, Mental Health | Not applicable | Not yet recruiting | City University of New York, School of Public Health | 3900 | 2028-01-01 | 2026-10-01 |
| Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations SD-ART - Hiv | Not applicable | Not yet recruiting | Yale University | 139 | 2027-10-01 | 2026-08-31 |
| Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida Workforce Development (WD) strategies, Quality Management (QM) and Mystery Shopper (MS) Feedback - Hiv | Not applicable | Not yet recruiting | Florida State University | 81 | 2027-06-01 | 2026-10-13 |
| Advanced HIV Re-engagement in Care ARC - Advanced HIV Disease | Not applicable | Not yet recruiting | University of Alabama at Birmingham | 724 | 2027-05-01 | 2026-07-23 |
| PositiveLinks for Youth (PL4Y) for Texas PositiveLinks for Youth Smartphone App - Human Immunodeficiency Virus, HIV | Not applicable | Not yet recruiting | The University of Texas Health Science Center at San Antonio | 600 | 2027-04-01 | 2026-09-04 |
| Medical Mistrust Among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex With Men (HLMSM) Navigators (peer navigator) training, delayed-intervention - Human Immunodeficiency Virus | Not applicable | Not yet recruiting | Wake Forest University Health Sciences | 144 | 2027-03-01 | 2026-04-30 |
| Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study No Marginal Cost Interventions, Low-Marginal Cost Interventions, Standard of Care - Human Immunodeficiency Virus | Not applicable | Not yet recruiting | Emory University | 223165 | 2027-03-01 | 2026-09-16 |
| Testing a Multi-Level Approach to Reduce Stigma for Women Living With HIV Labda Siku Moja, Total Facility Approach - HIV (Human Immunodeficiency Virus) | Not applicable | Not yet recruiting | RTI International | 680 | 2027-03-01 | 2026-10-19 |
| Pilot of an Intervention to Reduce Alcohol Use and Improve ART Adherence Among Men Living With HIV With Pregnant Partners in Uganda. Kisoboka Amaka, Screening and Referral - HIV Antiretroviral Therapy (ART) Adherence, Alcohol Consumption | Not applicable | Not yet recruiting | San Diego State University | 60 | 2027-02-01 | 2026-06-22 |
| Integrated Health Services (IHS): A Structural Intervention to Improve HIV/STI Screening and PrEP Navigation in Primary Care Integrated HIV/STI Testing and PrEP Navigation Model - HIV, STDs | Not applicable | Not yet recruiting | My Brother's Keeper, Inc. | 700 | 2027-02-01 | 2026-03-03 |
| Combating Related Epidemics in HCV Cepheid GeneXpert HCV Test, Abbott Determine HIV - 1/2 Ag/Ab, Abbott Determine HbsAg 2 - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV) | Phase 4 | Not yet recruiting | Duke University | 1280 | 2027-01-20 | 2026-10-15 |
| Innate-like and NK Signatures in Chronic-Treated HIV Infection INSTINCT-HIV Blood test - Human Immunodeficiency Virus Infection (HIV) | Not yet recruiting | Hospices Civils de Lyon | 100 | 2027-01-12 | 2026-09-30 | |
| Yuva Sath: A Peer-led Behavioral Intervention to Support Substance Use Treatment and HIV Prevention Among Young People Who Inject Drugs in India Yuva Sath - Hiv, Substance Use Disorders | Not applicable | Not yet recruiting | Massachusetts General Hospital | 60 | 2027-01-01 | 2025-10-22 |
| Study on Retention in Care and on Clinical Chracteristics of HIV-infected Women Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIKWO). Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF) - HIV 1 Infection | Not yet recruiting | Ente Ospedaliero Ospedali Galliera | 100 | 2026-12-15 | 2026-10-09 | |
| IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania IDEAS for Hope, Safety Planning Intervention - HIV - Human Immunodeficiency Virus, Suicide Prevention | Not applicable | Not yet recruiting | Duke University | 600 | 2026-12-01 | 2026-10-14 |
| Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV Dose Level 1 ACU-D1 ointment, Dose Level 2 ACU-D1 ointment, Dose Level 3 ACU-D1 ointment - Human Papilloma Virus, Human Immunodeficiency Virus | Phase 1 | Not yet recruiting | Emory University | 9 | 2026-12-01 | 2026-08-18 |
| Immunotherapy With Glatiramer Acetate in PLWHIV in Poor Immunological Responders on Antiretroviral Therapy - Study treatment arm group (Arm A): GLATIRAMER VIATRIS 40mg/ml - HIV - Human Immunodeficiency Virus | Phase 2 | Not yet recruiting | ANRS, Emerging Infectious Diseases | 36 | 2026-12-01 | 2026-10-01 |
| A Clinical Study of Ixazomib to Reactivate HIV and Reduce HIV Reservoir Size Ixazomib 4 mg, Placebo - HIV (Human Immunodeficiency Virus) | Phase 2 | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 45 | 2026-11-23 | 2026-10-19 |
| C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States Qualitative interviews, Focus groups - Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV) | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 3500 | 2026-11-10 | 2026-10-20 |
Showing 20 of 3101. Sign in to see all of them.
Acquired Immunodeficiency Syndrome (3029) · HIV Infections (1181) · AIDS-Related Complex (283) · Infections (171) · AIDS-Related Opportunistic Infections (125) · Sexually Transmitted Diseases (91) · Hepatitis C (86) · Substance-Related Disorders (85) · Tuberculosis (84) · Depression (61) · Sarcoma, Kaposi (61) · Pneumonia, Pneumocystis (56) · Medication Adherence (55) · Cytomegalovirus Infections (52) · Cytomegalovirus Retinitis (46)
Virus Diseases (3082) · Blood-Borne Infections (3079) · Genital Diseases (3079) · Urogenital Diseases (3079) · Lentivirus Infections (3073) · RNA Virus Infections (3070) · Retroviridae Infections (3070) · Immune System Diseases (3069) · Sexually Transmitted Diseases, Viral (3066) · Communicable Diseases (3065) · Immunologic Deficiency Syndromes (3063) · Sexually Transmitted Diseases (2988) · Infections (2930) · HIV Infections (1898)
Zidovudine (173) · Ritonavir (89) · dolutegravir (78) · Lamivudine (75) · Tenofovir (56) · efavirenz (50) · Didanosine (49) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (49) · Standard of Care (48) · Darunavir (44) · Emtricitabine (44) · Raltegravir Potassium (39) · Maraviroc (36) · Fluconazole (33) · Zalcitabine (33)
National Institute of Allergy and Infectious Diseases (NIAID) (332) · ViiV Healthcare (150) · University of California, San Francisco (77) · Columbia University (49) · Johns Hopkins University (41) · University of North Carolina, Chapel Hill (39) · Emory University (38) · University of Washington (38) · Massachusetts General Hospital (37) · Merck Sharp & Dohme LLC (36) · Gilead Sciences (35) · National Cancer Institute (NCI) (33) · Pfizer (33) · Yale University (33) · Bristol-Myers Squibb (31)
United States (1723) · South Africa (167) · Puerto Rico (128) · Canada (124) · Uganda (120) · France (112) · Spain (99) · Kenya (94) · United Kingdom (93) · China (89) · Germany (85) · Italy (67) · Brazil (57) · Thailand (56) · Belgium (53)
Harsha Thirumurthy, PhD (9) · Feinberg J (8) · Corey L (6) · Fischl MA (6) · Frederick L Altice, MD (6) · Marina Caskey, MD (6) · Robert Yarchoan, M.D. (6) · Christopher Hoffmann, MD, MPH (5)
PMID 32779730, PMID 32838558, PMID 17666313, PMID 20024643, PMID 22288567, PMID 26743093, PMID 33616229, PMID 36150048, PMID 40354181, PMID 10218526, PMID 11188837, PMID 16183552, PMID 18305915, PMID 18557952, PMID 19723613, PMID 20002869, PMID 20103953, PMID 20133267, PMID 20739268, PMID 20959530, PMID 21450595, PMID 21764468, PMID 22027640, PMID 22254197, PMID 22532465, PMID 22634184, PMID 23714781, PMID 24391139, PMID 24674234, PMID 24889337, PMID 24898272, PMID 24908550, PMID 25042234, PMID 25296098, PMID 25583164, PMID 26560326, PMID 26762403, PMID 27215559, PMID 27535056, PMID 28514277, PMID 29432228, PMID 29432231, PMID 29596110, PMID 29847477, PMID 30157896, PMID 30412360, PMID 30601062, PMID 30927547, PMID 30929147, PMID 31516033
2015 (9), 2008 (8), 2019 (8), 2023 (7), U24CA275417 (7), 2014 (6), 2009 (5), 2017 (5), UG1CA275402 (4), UM1CA121947 (4), 2018 (3), 2025 (3), P01AA029545 (3), R01AI083038 (3), R01HD071779 (3)